Dan Myers has been appointed as CEO of Leo Lens Pharma, according to a press release.
With more than 35 years of ophthalmic pharmaceutical experience and 21 years in leadership roles, Myers was the co-founder and CEO of Almira Sciences and a founding employee of Novartis Ophthalmics.
Leo Lens is currently in the process of submitting an investigational new drug application to the FDA for a proprietary contact lens to treat glaucoma. The company’s MediPrint printing technology process is used to manufacture the lens, which allows for the continuous delivery (Read more...)
Uncategorized